tti-622
pfizer
['dlbcl', 'tps7595', 'lymphoma', 'pfizer']
see more at #asco22 about 2 cohorts from the ongoing ph 1b part of a study evaluating dose, safety &amp; preliminary efficacy of a cd47-inhibiting fusion protein + an anti-cd20 targeting agent in pts w/ cd20+ r/r diffuse large b-cell #lymphoma #dlbcl tps7595 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ